Grifols S.A. ADR Stock
Price
Target price
€7.35
€7.35
4.260%
0.3
4.260%
-
05.06.25 / Frankfurt
WKN: A1J1E2 / Symbol: GRFS / Name: Grifols / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Grifols S.A. ADR Stock
Grifols S.A. ADR dominated the market today, gaining €0.30 (4.260%).
Pros and Cons of Grifols S.A. ADR in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Grifols S.A. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Grifols S.A. ADR | 4.260% | -0.704% | 9.302% | 7.634% | 1.439% | -39.744% | -60.048% |
| Cellectar BioSciences Inc. | -9.090% | 54.386% | 49.153% | -87.692% | 12.821% | -91.189% | - |
| Beximco Pharmaceuticals Ltd. GDR | 2.420% | -1.429% | 3.500% | -1.429% | 0.000% | -55.484% | -8.407% |
| SELLAS Life Sciences Group Inc | 0.140% | -5.305% | -6.176% | 9.846% | 51.753% | -47.673% | -52.918% |
Comments
Grifols, S.A. (NASDAQ: GRFS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Show more
Ratings data for GRFS provided by MarketBeat
Grifols, S.A. (NASDAQ: GRFS) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Show more
Ratings data for GRFS provided by MarketBeat
